FDA inspection
Janssen Biotech, Inc.: FDA inspection ending Jul 29, 2025
FDA inspection 1276933 · Voluntary Action Indicated (VAI) · Malvern, PA
Key facts
| Inspection ID | 1276933 |
|---|---|
| Firm | Janssen Biotech, Inc. |
| FEI number | 3001610451 |
| Address | 200 Great Valley Pkwy |
| City | Malvern |
| State | PA |
| ZIP | 19355 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Jul 29, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data